The Trojan Investment Funds all have an absolute return objective and any comparisons against indices are for illustrative purposes only. The Trojan Income Fund is an equity biased fund that aims to provide growing levels of income that are in excess of the yield offered by the UK equity market.
Name | % Net Assets |
---|---|
B.P. | 4.3% |
Royal Dutch Shell 'B' | 4.3% |
Vodafone | 3.6% |
GlaxoSmithKline | 3.4% |
HSBC Holdings | 3.2% |
Tesco | 3.2% |
Diageo | 3.0% |
Astra Zeneca | 3.0% |
British American Tobacco | 2.9% |
BG Group | 2.8% |
Key | % Net Assets |
---|---|
B.P. | 4.3% |
Royal Dutch Shell 'B' | 4.3% |
Vodafone | 3.6% |
GlaxoSmithKline | 3.4% |
Other | 84.4% |
Date | 21-Nov-2024 |
---|---|
NAV | 372.63p |
Currency | GBP |
Change | 1.77p |
% | 0.48% |
YTD change | 23.08p |
YTD % | 6.60% |
Fund Inception | 30/09/2004 |
---|---|
Fund Manager | Francis Brooke |
TER | 1.03 (31-Jan-2014) |
Minimum Investment | |
---|---|
Initial | £10000 |
Additional | £10,000 |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.00% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.22 |
You are here: research